Cargando…
Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial
BACKGROUND: Community-acquired pneumonia (CAP) is a major global disease. Parapneumonic effusions often complicate CAP and range from uninfected (simple) to infected (complicated) parapneumonic effusions and empyema (pus). CAP patients who have a pleural effusion at presentation are more likely to r...
Autores principales: | Fitzgerald, Deirdre B., Waterer, Grant W., Read, Catherine A., Fysh, Edward T., Shrestha, Ranjan, Stanley, Christopher, Muruganandan, Sanjeevan, Lan, Norris S. H., Popowicz, Natalia D., Peddle-McIntyre, Carolyn J., Rahman, Najib M., Gan, Seng Khee, Murray, Kevin, Lee, Yun Chor Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824804/ https://www.ncbi.nlm.nih.gov/pubmed/31651842 http://dx.doi.org/10.1097/MD.0000000000017397 |
Ejemplares similares
-
Associations of physical activity and quality of life in parapneumonic effusion patients
por: Lopez, Pedro, et al.
Publicado: (2023) -
Performance of procalcitonin in diagnosing parapneumonic pleural effusions: A clinical study and meta-analysis
por: He, Chao, et al.
Publicado: (2017) -
Malignant pleural mesothelioma presenting with remitting–relapsing pleural effusions: report of two cases
por: Muruganandan, Sanjeevan, et al.
Publicado: (2018) -
Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012) -
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)